Kamada (KMDA) Share-based Compensation (2012 - 2026)
Kamada (KMDA) recorded Share-based Compensation of $720,000 in the quarter ended Jun 30, 2026, up 657.9% from $95,000 a year earlier but down 10.0% from the prior quarter.
Powered by 
Analysis
Kamada (KMDA) Share-based Compensation (2012 - 2026) Analysis & Trends
On a TTM basis, Kamada's Share-based Compensation came in at $2.1 million as of Jun 30, 2026, up 213.6% year-over-year; for the year ended Dec 31, 2025, it was $845,000, down 3.3% from the prior year.
- Annual Share-based Compensation has a five-year compound annual growth rate of -2.9% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Share-based Compensation came in at $874,000 in the year ended Dec 31, 2024 (-33.5%), $1.31 million in the year ended Dec 31, 2023 (+14.0%), $1.15 million in the year ended Dec 31, 2022 (+118.0%) and $529,000 in the year ended Dec 31, 2021 (-45.9%).
- Quarterly Share-based Compensation has ranged from $25,000 in the quarter ended Dec 31, 2021 to $800,000 in the quarter ended Mar 31, 2026 over the past five years.
- On a year-over-year basis, Share-based Compensation has increased for three consecutive quarters, with growth averaging 120.2% over the last eight quarters.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 772.0% in the quarter ended Dec 31, 2022, against a decline of 79.8% in the quarter ended Dec 31, 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $800,000 (quarter ended Mar 31, 2026), $458,000 (quarter ended Dec 31, 2025) and $117,000 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Kamada | 497.25 Mn | 206.31 Mn | 22.47 Mn | 720,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 720,000.00 |
| Mar 31, 2026 | 800,000.00 |
| Dec 31, 2025 | 458,000.00 |
| Sep 30, 2025 | 117,000.00 |
| Jun 30, 2025 | 95,000.00 |
| Mar 31, 2025 | 175,000.00 |
| Dec 31, 2024 | 174,000.00 |
| Sep 30, 2024 | 224,000.00 |
| Jun 30, 2024 | 235,000.00 |
| Mar 31, 2024 | 241,000.00 |
| Dec 31, 2023 | 373,000.00 |
| Sep 30, 2023 | 312,000.00 |
| Jun 30, 2023 | 214,000.00 |
| Mar 31, 2023 | 415,000.00 |
| Dec 31, 2022 | 218,000.00 |
| Sep 30, 2022 | 366,000.00 |
| Jun 30, 2022 | 376,000.00 |
| Mar 31, 2022 | 193,000.00 |
| Dec 31, 2021 | 25,000.00 |
| Sep 30, 2021 | 134,000.00 |
API Access
Kamada Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=KMDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "KMDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=KMDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();